series-a
Stage
2
Investors
About
eNeura develops FDA-cleared single-pulse transcranial magnetic stimulation (sTMS) devices for the acute and preventive treatment of migraine in patients 12 years and older.
Explore eNeura's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.